Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
50%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (100.0%)

Trials by Status

recruiting125%
active_not_recruiting125%
completed250%

Recent Activity

2 active trials
Showing 4 of 4
completedphase_1

Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT04384146
active_not_recruiting

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

NCT01888198
recruiting

Registry for Esophageal and Gastroesophageal Junction Cancer

NCT06558786
completedphase_1

MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer

NCT02582931

Clinical Trials (4)

Showing 4 of 4 trials
NCT04384146Phase 1

Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Completed
NCT01888198

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

Active Not Recruiting
NCT06558786

Registry for Esophageal and Gastroesophageal Junction Cancer

Recruiting
NCT02582931Phase 1

MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4